Metraipolis › archive › dc_08dcf3015bcd

Exploring Human Epidermal Growth Factor Receptor 2 (HER2)-Low Early Breast Cancer in a Moroccan Population: Clinical Characteristics and Survival Outcomes — Europe PMC PMID:40959359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40959359
DOI
10.7759/cureus.90253
License (as archived)
solo-consultazione
Archived
2026-11-10T14:11:08.842Z
SHA-256 of the archived text
dbb82f0666dd6dfe4f0cc54feb038d3515b7cf8c244c83013df905d20b517880
Stable URL of this page
https://metraipolis.com/documento/dc_08dcf3015bcd

How to cite

Exploring Human Epidermal Growth Factor Receptor 2 (HER2)-Low Early Breast Cancer in a Moroccan Population: Clinical Characteristics and Survival Outcomes — Europe PMC PMID:40959359 — Europe PMC (en), https://europepmc.org/article/MED/40959359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08dcf3015bcd (Metraipolis archive dc_08dcf3015bcd, sha256 dbb82f0666dd6dfe4f0cc54feb038d3515b7cf8c244c83013df905d20b517880)
BibTeX
@misc{dc08dcf3015bcd,
  title = {Exploring Human Epidermal Growth Factor Receptor 2 (HER2)-Low Early Breast Cancer in a Moroccan Population: Clinical Characteristics and Survival Outcomes — Europe PMC PMID:40959359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40959359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08dcf3015bcd; sha256 dbb82f0666dd6dfe4f0cc54feb038d3515b7cf8c244c83013df905d20b517880},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40959359. Agents can read the archived copy with the MCP tool read_document.